BeiGene (China) Top Management
688235 Stock | 165.63 0.84 0.51% |
BeiGene employs about 10.6 K people. The company is managed by 14 executives with a total tenure of roughly 24734 years, averaging almost 1766.0 years of service per executive, having 757.14 employees per reported executive. Analysis of BeiGene's management performance can provide insight into the company performance.
Xiaodong Wang Chairman CoChairman CoFounder |
Xiaobin Wu President President COO |
BeiGene |
BeiGene Management Team Effectiveness
The company has return on total asset (ROA) of (0.0958) % which means that it has lost $0.0958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2322) %, meaning that it generated substantial loss on money invested by shareholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. At present, BeiGene's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 11.7 M, whereas Non Current Assets Total are forecasted to decline to about 1.1 B.As of December 17, 2024, Common Stock Shares Outstanding is expected to decline to about 1.3 B
BeiGene Workforce Comparison
BeiGene is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 46,820. BeiGene totals roughly 10,600 in number of employees claiming about 23% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14. BeiGene Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BeiGene Price Series Summation is a cross summation of BeiGene price series and its benchmark/peer.
BeiGene Notable Stakeholders
A BeiGene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BeiGene often face trade-offs trying to please all of them. BeiGene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BeiGene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Oyler | Executive CoFounder | Profile | |
Xiaodong Wang | CoChairman CoFounder | Profile | |
Xiaobin Wu | President COO | Profile | |
Aaron Rosenberg | CFO Officer | Profile | |
Chan Lee | General VP | Profile | |
Titus Ball | VP Officer | Profile | |
Liza Heapes | Head Relations | Profile | |
Wang Lai | Global RD | Profile | |
Julia Wang | Executive Officer | Profile | |
Jason Radford | Senior Development | Profile | |
Yang Ji | Chief Officer | Profile | |
Jaspreet MD | Senior Strategy | Profile | |
Melika Davis | Clinical Head | Profile | |
Yan Qi | Senior China | Profile |
About BeiGene Management Performance
The success or failure of an entity such as BeiGene often depends on how effective the management is. BeiGene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BeiGene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BeiGene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BeiGene is entity of China. It is traded as Stock on SHG exchange.
Please note, the presentation of BeiGene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BeiGene's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BeiGene's management manipulating its earnings.
BeiGene Workforce Analysis
Traditionally, organizations such as BeiGene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BeiGene within its industry.BeiGene Manpower Efficiency
Return on BeiGene Manpower
Revenue Per Employee | 232K | |
Revenue Per Executive | 175.6M | |
Net Loss Per Employee | 83.2K | |
Net Loss Per Executive | 63M | |
Working Capital Per Employee | 225.8K | |
Working Capital Per Executive | 171M |
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world |